View Agent
| Agent Info | |
| Agent: | BIBF 1120 |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | NA |
| Classification: | a novel, orally available, potent triple angiokinase inhibitor that predominantly blocks the VEGF receptors 1 to 3, FGFR 1 to 3, and PDGF receptor α and β tyrosine kinases at nanomolar concentrations |
| Target: | VEGFR 1-3 FGFR 1-3 PDFGR α and β |
| KEGG Pathway: | tumor angiogenesis |
| Wiki Pathway: | NA |